aluminium chloride

Small moleculeexperimental

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum sulfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall. — NCATS

Clinical trial activity

2 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1

Earliest trial started Mar 31, 2016 (NCT03433859)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Loading structure…

SMILES

[Al+3]
Mol. weight
26.9815386 g/mol

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05079217Phase 4Nov 1, 2021Government of China, Sinovac Biotech Co., Ltd
NCT03433859Phase 3Mar 31, 2016Direction Centrale du Service de Santé des Armées, Hôpital Clermont-Tonnerre
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Direction Centrale du Service de Santé des ArméesGovernment1112016
Government of ChinaGovernment1012021
Hôpital Clermont-TonnerreAcademic/Hospital1012016
Sinovac Biotech Co., LtdFor profit1112021
4 organizations
Page 1 / 1